Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
7.95
+0.06 (0.76%)
At close: Aug 11, 2026, 4:00 PM EDT
7.92
-0.03 (-0.38%)
After-hours: Aug 11, 2026, 7:56 PM EDT
Novavax Market Cap
Novavax has a market cap or net worth of $1.31 billion as of August 11, 2026. Its market cap has decreased by -3.54% in one year.
Market Cap
1.31B
Enterprise Value
889.30M
1-Year Change
-3.54%
Ranking
Category
Stock Price
$7.95
ChartMarket Cap Chart
Since December 1, 1998, Novavax's market cap has increased from $25.70M to $1.31B, an increase of 5,002.41%. That is a compound annual growth rate of 15.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 1.31B | 20.08% |
| Dec 31, 2025 | 1.09B | -15.21% |
| Dec 31, 2024 | 1.29B | 125.87% |
| Dec 29, 2023 | 570.20M | -29.34% |
| Dec 30, 2022 | 807.00M | -92.54% |
| Dec 31, 2021 | 10.82B | 52.38% |
| Dec 31, 2020 | 7.10B | 6,609.55% |
| Dec 31, 2019 | 105.80M | -84.98% |
| Dec 31, 2018 | 704.40M | 81.13% |
| Dec 29, 2017 | 388.90M | 13.78% |
| Dec 30, 2016 | 341.80M | -84.90% |
| Dec 31, 2015 | 2.26B | 60.10% |
| Dec 31, 2014 | 1.41B | 32.47% |
| Dec 31, 2013 | 1.07B | 281.83% |
| Dec 31, 2012 | 279.60M | 92.96% |
| Dec 30, 2011 | 144.90M | -46.33% |
| Dec 31, 2010 | 270.00M | 8.56% |
| Dec 31, 2009 | 248.70M | 90.28% |
| Dec 31, 2008 | 130.70M | -36.71% |
| Dec 31, 2007 | 206.50M | -18.35% |
| Dec 29, 2006 | 252.90M | 33.74% |
| Dec 30, 2005 | 189.10M | 46.70% |
| Dec 31, 2004 | 128.90M | -28.82% |
| Dec 31, 2003 | 181.10M | 182.53% |
| Dec 31, 2002 | 64.10M | -80.46% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inhibrx Biosciences | 1.37B |
| Monte Rosa Therapeutics | 1.35B |
| Aktis Oncology | 1.33B |
| Immatics | 1.33B |
| LB Pharmaceuticals | 1.31B |
| Jade Biosciences | 1.29B |
| Vor Biopharma | 1.27B |
| MannKind | 1.26B |